Product Overview
| Product Details | Information |
|---|---|
| Product Name | Ceftriaxone & Tazobactam Injection |
| Strength | 562.5 mg |
| Composition | Ceftriaxone 500 mg + Tazobactam 62.5 mg |
| Dosage Form | Sterile Powder for Injection |
| Administration | IM / IV |
| Therapeutic Category | Broad-Spectrum Antibiotic |
| Packaging | Sterile Export Packaging |
| Country of Origin | India |
Key Features
- Dual-action antibiotic formulation
- Ceftriaxone and Tazobactam combination
- Broad-spectrum antibacterial activity
- Sterile injectable preparation
- WHO-GMP certified manufacturing
- High pharmaceutical purity
- Stable formulation
- Batch-tested quality
- Export-quality packaging
- Manufactured under international standards
Ceftriaxone & Tazobactam Injection: 562.5 mg Supplier for Canberra, Australia
High-Quality Combination Antibiotic Injection from India
Ernest Oncology offers Ceftriaxone & Tazobactam Injection 562.5 mg, a sterile injectable antibiotic formulation containing Ceftriaxone 500 mg and Tazobactam 62.5 mg. Manufactured in India using advanced pharmaceutical technology, the product is produced in WHO-GMP certified facilities with strict quality management systems to ensure purity, consistency, and patient safety.
Designed for intramuscular (IM) and intravenous (IV) administration, this injectable antibiotic is intended for use under the guidance of qualified healthcare professionals.Product Description
Ceftriaxone & Tazobactam Injection 562.5 mg combines the antibacterial action of Ceftriaxone with the enzyme-inhibiting properties of Tazobactam. This combination helps maintain the effectiveness of Ceftriaxone by protecting it against beta-lactamase enzymes produced by certain bacteria.
The medicine is supplied as a sterile powder for injection and should be administered by qualified healthcare professionals through intramuscular (IM) or intravenous (IV) routes.
Mechanism of Action
The formulation provides antibacterial activity through two complementary mechanisms.
- Ceftriaxone inhibits bacterial cell wall synthesis, resulting in bacterial destruction.
- Tazobactam inhibits beta-lactamase enzymes that can inactivate certain antibiotics, thereby helping Ceftriaxone remain effective.
Together they provide enhanced antibacterial coverage against susceptible bacterial pathogens.
Recommended Dosage
Dosage should always be determined by a qualified healthcare professional.
The appropriate dose depends upon:
- Nature of infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Individual clinical assessment
This medicine should only be administered under medical supervision.
Side Effects
Like other injectable antibiotics, some individuals may experience temporary side effects.
Possible reactions include:
- Injection site pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary elevation of liver enzyme levels
Consult your healthcare provider if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Use only under qualified medical supervision.
- Inform your healthcare provider about any known allergies before treatment.
- Complete the prescribed course.
- Follow all medical instructions carefully.
- Keep out of reach of children.
- Do not use after the expiry date.
Storage Information
- Store below 25°C
- Protect from moisture
- Avoid direct sunlight
- Keep in the original packaging
- Do not freeze
- Use before the expiry date
Quality Assurance
At Ernest Oncology, every batch is produced under internationally recognized pharmaceutical quality systems to ensure dependable product quality.
Our Quality Standards
- WHO-GMP certified manufacturing facilities
- Sterile production environment
- Comprehensive batch testing
- Product traceability
- Export-grade packaging
- Controlled storage conditions
- Documentation verification
- Continuous quality monitoring
Documentation
The following export documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP) (where applicable)
- Batch Manufacturing Record* (where available)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
Canberra Pharmaceutical Market Information
Australia maintains one of the world's most respected healthcare systems, emphasizing pharmaceutical quality, patient safety, and evidence-based medical care. Canberra's hospitals, healthcare institutions, and specialist clinics continue to rely on medicines manufactured according to internationally accepted pharmaceutical standards.
Indian pharmaceutical manufacturers continue to support global healthcare by producing reliable sterile injectable medicines through advanced manufacturing technologies and internationally recognized quality systems.
Why Choose Indian Pharmaceutical Exports
India has become one of the world's leading pharmaceutical manufacturing countries because of its quality-focused production and internationally recognized manufacturing standards.
Advantages of Indian Pharmaceutical Products
- WHO-GMP certified manufacturing units
- Modern sterile manufacturing technology
- International quality compliance
- High pharmaceutical purity
- Reliable production consistency
- Advanced quality assurance systems
- Export-standard packaging
- Continuous product monitoring
- Globally trusted pharmaceutical expertise
- Innovation-driven manufacturing excellence
